Literature DB >> 18036907

Myocardial protection during elective coronary artery bypass grafting using high-dose insulin therapy.

Turki B Albacker1, George Carvalho, Thomas Schricker, Kevin Lachapelle.   

Abstract

BACKGROUND: Coronary artery bypass grafting (CABG) with cardioplegic cardiac arrest and cardiopulmonary bypass (CPB) is associated with myocardial injury. The aim of this study was to investigate whether high-dose insulin therapy has a myocardial protective effect by enhancing early metabolic recovery of the arrested heart during revascularization.
METHODS: A total of 44 patients undergoing elective CABG were randomized to receive intraoperative titrated intravenous insulin infusion (n = 22) or a fixed high-dose systemic insulin infusion at 5 mU/kg/min (n = 22). Blood samples were collected simultaneously from the radial artery and the coronary sinus before starting CPB and at 5 and 10 minutes after the release of the aortic cross-clamp to determine lactate, oxygen saturation, and hemoglobin concentration. Lactate extraction/excretion and myocardial oxygen extraction were calculated and compared between the two groups. The change in cardiac indices was determined immediately postoperatively as a measure of functional recovery, and the troponin I level was measured 4 hours postoperatively as an indicator of myocardial protection.
RESULTS: Operative characteristics, including CPB and aortic cross-clamp time, were similar between the two groups. Arterial oxygen content was similar in both groups. The high-dose insulin therapy group had early extraction of lactate and higher oxygen extraction immediately postoperatively compared with the standard group. In addition, the high-dose insulin group had a lower troponin I level 4 hours postoperatively, with greater improvement in cardiac indices.
CONCLUSIONS: High-dose insulin therapy promotes early metabolic recovery of the heart during elective CABG, leading to better myocardial protection and functional recovery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18036907     DOI: 10.1016/j.athoracsur.2007.07.001

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Hyperinsulinemic Normoglycemia during Cardiac Surgery Reduces a Composite of 30-day Mortality and Serious In-hospital Complications: A Randomized Clinical Trial.

Authors:  Andra E Duncan; Daniel I Sessler; Hiroaki Sato; Tamaki Sato; Keisuke Nakazawa; George Carvalho; Roupen Hatzakorzian; Takumi Codere-Maruyama; Alaa Abd-Elsayed; Somnath Bose; Tamer Said; Maria Mendoza-Cuartas; Hyndhavi Chowdary; Edward J Mascha; Dongsheng Yang; A Marc Gillinov; Thomas Schricker
Journal:  Anesthesiology       Date:  2018-06       Impact factor: 7.892

2.  Hyperinsulinemic Normoglycemia Does Not Meaningfully Improve Myocardial Performance during Cardiac Surgery: A Randomized Trial.

Authors:  Andra E Duncan; Babak Kateby Kashy; Sheryar Sarwar; Akhil Singh; Olga Stenina-Adognravi; Steffen Christoffersen; Andrej Alfirevic; Shiva Sale; Dongsheng Yang; James D Thomas; Marc Gillinov; Daniel I Sessler
Journal:  Anesthesiology       Date:  2015-08       Impact factor: 7.892

Review 3.  JAK redux: a second look at the regulation and role of JAKs in the heart.

Authors:  Mazen Kurdi; George W Booz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

4.  Association between insulin dosage and insulin usage time, and coronary artery lesions in patients with type 2 diabetes and coronary heart disease.

Authors:  Xiao-Li Luo; Qing-Kai Yan; Yan Wang; Hui Fang; Hong-Yong Wang; Yun Bai; Chun-Yu Zeng; Xu-Kai Wang
Journal:  Exp Ther Med       Date:  2016-02-29       Impact factor: 2.447

5.  Glycemic Control Regimens in the Prevention of Surgical Site Infections: A Meta-Analysis of Randomized Clinical Trials.

Authors:  Jing Lai; Qihong Li; Ying He; Shiyue Zou; Xiaodong Bai; Sanjay Rastogi
Journal:  Front Surg       Date:  2022-03-25

6.  Change in the perioperative blood glucose and blood lactate levels of non-diabetic patients undergoing coronary bypass surgery.

Authors:  Chunjian Shen; Tianxiang Gu; Lili Gu; Zhongyi Xiu; Zhiwei Zhang; Enyi Shi; Yuhai Zhang; Chun Wang
Journal:  Exp Ther Med       Date:  2013-08-22       Impact factor: 2.447

7.  Modified Glucose-Insulin-Potassium Regimen Provides Cardioprotection With Improved Tissue Perfusion in Patients Undergoing Cardiopulmonary Bypass Surgery.

Authors:  Kun Zhao; Yue Zhang; Jia Li; Qin Cui; Rong Zhao; Wensheng Chen; Jincheng Liu; Bijun Zhao; Yi Wan; Xin-Liang Ma; Shiqiang Yu; Dinghua Yi; Feng Gao
Journal:  J Am Heart Assoc       Date:  2020-03-10       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.